Pharmacokinetic Drug Interactions with Oral Contraceptives
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Oral contraceptive steroids are used by an estimated 60 to 70 million women world-wide. Over the past 20 years there have been both case reports and clinical studies on the topic of drug interactions with these agents. Some of the interactions are of definite therapeutic relevance, whereas others can be discounted as being of no clinical significance. Pharmacological interactions between oral contraceptive steroids and other compounds may be of 2 kinds: (a) drugs may impair the efficacy of oral contraceptive steroids, leading to breakthrough bleeding and pregnancy (in a few cases, the activity of the contraceptive is enhanced); (b) oral contraceptive steroids may interfere with the metabolism of other drugs. A number of anticonvulsants (phenobarbital, phenytoin, carbamazepine) are enzyme-inducing agents and thereby increase the clearance of the oral contraceptive steroids. Valproic acid has no enzyme-inducing properties, and thus women on this anticonvulsant can rely on their low dose oral contraceptive steroids for contraceptive protection. Researchers are now beginning to unravel the molecular basis of this interaction, with evidence of specific forms of cytochrome P450 (P450IIC and IIIA gene families) being induced by phenobarbital. Rifampicin, the antituberculous drug, also induces a cytochrome P450 which is a product of the P450IIIA gene subfamily. This isozyme is one of the major forms involved in 2-hydroxylation of ethinylestradiol. Broad spectrum antibiotics have been implicated in causing pill failure; case reports document the interaction, and general practitioners are convinced that it is real. The problem remains that there is still no firm clinical pharmacokinetic evidence which indicates that blood concentrations of oral contraceptive steroids are altered by antibiotics. However, perhaps this should not be a surprise, given that the incidence of the interaction may be very low. It is suggested that an individual at risk will have a low bioavailability of ethinylestradiol, a large enterohepatic recirculation and gut flora particularly susceptible to the antibiotic being used. Two drugs, ascorbic acid (vitamin C) and paracetamol (acetaminophen), give rise to increased blood concentrations of ethinylestradiol due to competition for sulphation. The interactions could have some significance to women on oral contraceptive steroids who regularly take high doses of either drug. Although on theoretical grounds adsorbents (e.g. magnesium trisilicate, aLuminium hydroxide, activated charcoal and kaolin) could be expected to interfere with oral contraceptive efficacy, there is no firm evidence that this is the case. Similarly, there is no evidence that smoking alters the pharmacokinetics of oral contraceptive steroids. These agents are now well documented as being able to alter the pharmacokinetics of other concomitantly administered drugs.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral contraceptive steroids may inhibit the metabolism of some BZDs that undergo oxidative metabolism or nitroreduction and accelerate the metabolism of some BZDs that are conjugated.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [60]
Citations
Cites
Michnovicz, J. J., Hershcopf, R. J., Naganuma, H., Bradlow, H. L., & Fishman, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152101 · Cited by 658
Kronbach, T., Fischer, V., & Meyer, U. A. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.87 · Cited by 533
Kinetics and metabolism of paracetamol and phenacetin.
Prescott, L. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb01812.x · Cited by 454
LACTATE AS ENERGY SOURCE FOR BRAIN IN GLUCOSE-6-PHOSPHATASE DEFICIENT CHILD
Fernandes, J., Berger, R., & Smit, G. P. A. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90257-4 · Cited by 319
Combalbert, J., Fabre, I., Fabre, G., Dalet, I., Derancourt, J., Cano, J. P., & Maurel, P. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08744-6 · Cited by 306
Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene
Guengerich, F. P. (1990) · Chemical Research in Toxicology · doi:10.1021/tx00016a015 · Cited by 279
Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
Guengerich, F. P. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13356-7 · Cited by 237
Maurer, G. (1985) · PubMed · Cited by 204
Impairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives
Abernethy, D. R., & Todd, E. L. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544361 · Cited by 195
Effects of age and cigarette smoking on propranolol disposition
Vestal, R. E., Wood, A. J. J., Branch, R. A., Shand, D. G., & Wilkinson, G. R. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt19792618 · Cited by 186
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Gender Effects in Pharmacokinetics and Pharmacodynamics
Harris, R. Z., Benet, L. Z., & Schwartz, J. B. (1995) · Drugs · doi:10.2165/00003495-199550020-00003 · Cited by 506
The Influence of Sex on Pharmacokinetics
Schwartz, J. B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00001 · Cited by 467
Metadata
- Authors
- Back, D. J., & Orme, M. L.
- Affiliations
- University of Liverpool (GB)
- ORCID
- Back, David J.
- Venue
- Clinical Pharmacokinetics
- Published
- 1990-06
- Volume
- 18
- Issue
- 6
- Pages
- 472-484
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W2092214166
- Cited by
- 209
- References
- 110
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 5 · 2022: 1 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 11
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Agricultural Fund for Rural Development
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- oral contraceptives, drug interactions, pharmacokinetics, ethinyl estradiol, cytochrome P450 induction, enzyme-inducing anticonvulsants, phenobarbital, rifampicin, valproic acid, antibiotics, breakthrough bleeding, contraceptive failure, enterohepatic circulation, vitamin C, paracetamol
- MeSH terms
- Animals, Contraceptives, Oral, Drug Interactions, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic Drug Interactions with Oral Contraceptives. https://app.cochat.ai/papers/10.2165/00003088-199018060-00004
- The paper
- Back, D. J., & Orme, M. L. (1990). Pharmacokinetic Drug Interactions with Oral Contraceptives. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-199018060-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.